Dynamic Active U.S. Equity ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy

65

DXUS.TO
Dynamic Active U.S. Equity ETF

Last Price:

$33.16

Seasonality Move:

10.29%

Sell

42

NKTR
Nektar Therapeutics

Last Price:

$44.85

Seasonality Move:

11.58%

Buy

65

Dynamic Active U.S. Equity ETF (DXUS.TO) is a Buy

Is Dynamic Active U.S. Equity ETF a Buy, Sell or Hold?

The current Dynamic Active U.S. Equity ETF [DXUS.TO] share price is $33.56. The Score for DXUS.TO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
DXUS.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

42

Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DXUS.TO Stock Price Chart

What is Dynamic Active U.S. Equity ETF's stock price today?

The Dynamic Active U.S. Equity ETF share price today is $33.56

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DXUS.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

The Nektar Therapeutics share price today is $49.16

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

DXUS.TO Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.12	Sell
Relative Strength Index (14 RSI):	35.11	Sell
Chaikin Money Flow:	1925	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

NKTR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.43	Sell
Relative Strength Index (14 RSI):	38.92	Sell
Chaikin Money Flow:	341847	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	( - )	Buy
Bollinger Bands (100):	( - )	Buy

DXUS.TO Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	34.16	Sell
20-day SMA:	34.34	Sell
50-day SMA:	34.33	Sell
200-day SMA:	31.48	Buy
8-day EMA:	34.03	Sell
20-day EMA:	34.25	Sell
50-day EMA:	34.15	Sell
200-day EMA:	32.2	Buy

NKTR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	54.87	Sell
20-day SMA:	57.43	Sell
50-day SMA:	58.05	Sell
200-day SMA:	31.04	Buy
8-day EMA:	54.11	Sell
20-day EMA:	56.28	Sell
50-day EMA:	55.42	Sell
200-day EMA:	38.13	Buy

Dynamic Active U.S. Equity ETF Earnings Growth & DXUS.TO Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Dynamic Active U.S. Equity ETF Technical Analysis

	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16
	Dec
	03	04	05	08	09	10	11	12	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12	Dec 15	Dec 16
	Dec
	03	04	05	08	09	10	11	12	15	16
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):